Maynard Um
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Prothena Corp (PRTA)
-
-
-
-
-
-
-
Prothena Corp. (PRTA) Tops Q3 EPS by 4c
-
-
-
-
-
-
-
Prothena Corp (PRTA) PT Lowered to $10 at RBC Capital
-
-
-
-
-
-
-
Prothena Corp. (PRTA) Partner Roche to Advance Prasinezumab into Phase III Development for Early-Stage Parkinson's
-
-
-
-
-
-
-
Prothena Corp. (PRTA) announces Phase 3 trial for Birtamimab did not meet endpoint
-
-
-
-
-
-
-
Kuehn Law Encourages Investors of Prothena Corporation PLC to Contact Law Firm
-
-
-
-
-
-
-
Prothena Corp. (PRTA) Tops Q3 EPS by 8c
-
422,382 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

